JPRN-UMIN000009016已完成未知
Study of second-generation 5-HT3-receptor antagonist; palonosetron for prevention of nausea and emesis in patients receiving chemotherapy including cisplatin for gastric cancer. - Effect of palonosetron in patient receiving chemotherapy including cisplatin for gastric cancer.
Digestive Disease Support Organization (DDSO)0 个研究点目标入组 75 人开始时间: 2012年10月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 75
研究概览
简要总结
Complete response rate: 91.6% Complete protectionrate: 66.7%
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable(—)
- 性别
- All
入选标准
- 未提供
排除标准
- •1) patients with serious hepatic insufficiency or renal failure. 2) patients with emesis within 24 hours before first administrating of cisplatin. 3) patients who were administered antiemetic drugs within 48 hours before first administrating of cisplatin. 4) patients with emetic factor except for chemotherapy 5) patient who was intended radiation therapy 6) patients judged inappropriate for this study by physicians. 7) patients who received Pimozide.
研究者
相似试验
Unknown
早期 1 期
Clinical Trial Assessing 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Anterior Resection SyndromeAnterior Resection SyndromeNCT02869984Seoul National University Hospital100
暂停
不适用
The efficacy of serotonin 5HT3 receptor antagonist Granisetron for surgical patients who have postoperative nausea and vomitingJPRN-UMIN000019962Yotsuya Medical Cube60
已完成
不适用
Comparison of the 5-HT3 receptors antagonists effect for preventing postoperative nausea and vomiting in morbid obese patients undergoing laparoscopic bariatric surgeryMental and behavioral disordersKCT0003873Soon Chun Hyang University Hospital Seoul140
尚未招募
2 期
The Safety and Efficacy of 5-HT3 Receptor Antagonist (Ramosetron) for the Treatment of Fecal IncontinenceFecal IncontinenceNCT06166615Seoul National University Hospital148
已完成
2 期
Phase II study of R-CHOP and R-high-dose MTX therapy for IVLBCL (PRIMEUR-IVL)Intravascular large B-cell lymphomaJPRN-UMIN000005707IVL study group in Japan38
